Aldesleukin Recruiting Phase 0 Trials for Metastatic Malignant Neoplasm in the Brain / Metastatic Malignant Neoplasm / HLA-A2 Positive Cells Present Treatment

IndicationsStatusPurposePhase
RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT02774291Anti-ESO (Cancer/Test Antigen) mTCR-transduced Autologous Peripheral Blood Lymphocytes and Combination Chemotherapy in Treating Patients With Metastatic Cancer That Expresses NY-ESO-1